These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35132603)

  • 41. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management.
    Savla SR; Prabhavalkar KS; Bhatt LK
    Expert Rev Anti Infect Ther; 2021 Nov; 19(11):1397-1413. PubMed ID: 33832398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal antibody therapy in COVID-19.
    Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic Potential of P2X7 Purinergic Receptor Modulation in the Main Organs Affected by the COVID-19 Cytokine Storm.
    Batista Simões JL; Sobierai LD; Pereira SM; Rodrigues Dos Santos MV; Bagatini MD
    Curr Pharm Des; 2022; 28(22):1798-1814. PubMed ID: 35838210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID-19.
    Muhammad A; Forcados GE; Sani H; Ndidi US; Adamu A; Katsayal BS; Sadiq IZ; Abubakar YS; Sulaiman I; Abubakar IB; Yusuf AP; Malami I; Ibrahim S; Abubakar MB
    J Food Biochem; 2022 May; 46(5):e14079. PubMed ID: 35060145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary predictive criteria for COVID-19 cytokine storm.
    Caricchio R; Gallucci M; Dass C; Zhang X; Gallucci S; Fleece D; Bromberg M; Criner GJ;
    Ann Rheum Dis; 2021 Jan; 80(1):88-95. PubMed ID: 32978237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperferritinemia in patients with COVID-19: An opportunity for iron chelation?
    Vlahakos VD; Marathias KP; Arkadopoulos N; Vlahakos DV
    Artif Organs; 2021 Feb; 45(2):163-167. PubMed ID: 32882061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
    Torabi-Rahvar M; Rezaei N
    Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
    Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
    Cell; 2021 Jan; 184(1):149-168.e17. PubMed ID: 33278357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
    Menegazzi M; Campagnari R; Bertoldi M; Crupi R; Di Paola R; Cuzzocrea S
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19.
    Prasad M; Leon M; Lerman LO; Lerman A
    Mayo Clin Proc; 2021 Dec; 96(12):3099-3108. PubMed ID: 34863398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.
    Anka AU; Tahir MI; Abubakar SD; Alsabbagh M; Zian Z; Hamedifar H; Sabzevari A; Azizi G
    Scand J Immunol; 2021 Apr; 93(4):e12998. PubMed ID: 33190302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
    Almerie MQ; Kerrigan DD
    Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Metformin: one of the possible options to reduce the mortality of severe coronavirus disease 2019?].
    Pan Y; Han R; He Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1131-1134. PubMed ID: 33081905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine storm associated with severe COVID-19 infections: The potential mitigating role of omega-3 fatty acid triglycerides in the ICU.
    Driscoll DF; Bistrian BR
    FASEB J; 2023 Aug; 37(8):e23066. PubMed ID: 37389478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytokine storm in COVID-19 and malaria: Annals of pro-inflammatory cytokines.
    Qidwai T
    Cytokine; 2024 Jan; 173():156420. PubMed ID: 37976701
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eicosanoids Signals in SARS-CoV-2 Infection: A Foe or Friend.
    Rahman MS; Hossain MS
    Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37878227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy.
    Wang L; Zhang Y; Zhang S
    Front Cardiovasc Med; 2020; 7():78. PubMed ID: 32426374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity.
    Buicu AL; Cernea S; Benedek I; Buicu CF; Benedek T
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33916917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MS-based targeted profiling of oxylipins in COVID-19: A new insight into inflammation regulation.
    Biagini D; Franzini M; Oliveri P; Lomonaco T; Ghimenti S; Bonini A; Vivaldi F; Macera L; Balas L; Durand T; Oger C; Galano JM; Maggi F; Celi A; Paolicchi A; Di Francesco F
    Free Radic Biol Med; 2022 Feb; 180():236-243. PubMed ID: 35085774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multimodal Benefits of Exercise in Patients With Multiple Sclerosis and COVID-19.
    Razi O; Tartibian B; Laher I; Govindasamy K; Zamani N; Rocha-Rodrigues S; Suzuki K; Zouhal H
    Front Physiol; 2022; 13():783251. PubMed ID: 35492581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.